12/24
07:01 pm
sny
Sanofi to Buy Dynavax to Boost Vaccines Business [Yahoo! Finance]
Neutral
Report
Sanofi to Buy Dynavax to Boost Vaccines Business [Yahoo! Finance]
12/24
02:17 pm
sny
What Sanofi Is Getting Through The Acquisition Of Dynavax [Seeking Alpha]
Neutral
Report
What Sanofi Is Getting Through The Acquisition Of Dynavax [Seeking Alpha]
12/24
11:21 am
sny
Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise [Yahoo! Finance]
Low
Report
Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise [Yahoo! Finance]
12/24
09:33 am
sny
BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance]
Low
Report
BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance]
12/24
09:29 am
sny
BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance Canada]
Low
Report
BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance Canada]
12/24
08:03 am
sny
Biggest Mover Wednesday: Dynavax Stock Soars on $2.2 billion Acquisition Deal [Yahoo! Finance]
Low
Report
Biggest Mover Wednesday: Dynavax Stock Soars on $2.2 billion Acquisition Deal [Yahoo! Finance]
12/24
07:04 am
sny
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion [CNBC]
Low
Report
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion [CNBC]
12/24
06:55 am
sny
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion [Yahoo! Finance]
Low
Report
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion [Yahoo! Finance]
12/24
01:36 am
sny
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline [Yahoo! Finance]
Low
Report
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline [Yahoo! Finance]
12/24
01:18 am
sny
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis [Yahoo! Finance]
Low
Report
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis [Yahoo! Finance]
12/24
01:15 am
sny
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
Low
Report
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
12/24
01:00 am
sny
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Low
Report
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
12/23
11:33 pm
sny
Sanofi (ENXTPA:SAN): Revisiting Valuation After a Recent Share Price Rebound [Yahoo! Finance]
Low
Report
Sanofi (ENXTPA:SAN): Revisiting Valuation After a Recent Share Price Rebound [Yahoo! Finance]
12/23
10:16 am
sny
Press Release: Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia [Yahoo! Finance]
Low
Report
Press Release: Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia [Yahoo! Finance]
12/23
09:17 am
sny
Local Organ, Eye and Tissue Donors, Transplant Recipients and Living Donors to be Honored on the 2026 OneLegacy Donate Life Rose Parade® Float on New Year's Day [Yahoo! Finance]
Low
Report
Local Organ, Eye and Tissue Donors, Transplant Recipients and Living Donors to be Honored on the 2026 OneLegacy Donate Life Rose Parade® Float on New Year's Day [Yahoo! Finance]
12/23
09:06 am
sny
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
Neutral
Report
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
12/23
01:00 am
sny
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Low
Report
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
12/22
12:55 pm
sny
Sanofi: Information concerning the total number of voting rights and shares - November 2025 [Yahoo! Finance]
Low
Report
Sanofi: Information concerning the total number of voting rights and shares - November 2025 [Yahoo! Finance]
12/22
09:49 am
sny
Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals [Yahoo! Finance]
Low
Report
Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals [Yahoo! Finance]
12/20
09:32 am
sny
Regeneron: The Turnaround Is Gaining Steam [Seeking Alpha]
Low
Report
Regeneron: The Turnaround Is Gaining Steam [Seeking Alpha]
12/19
03:11 pm
sny
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation [Yahoo! Finance]
Low
Report
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation [Yahoo! Finance]
12/19
02:21 pm
sny
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Low
Report
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
12/19
06:51 am
sny
Weekly Recap: 13 Health Press Releases You Need to See [Yahoo! Finance]
Low
Report
Weekly Recap: 13 Health Press Releases You Need to See [Yahoo! Finance]
12/19
06:15 am
sny
Global Pulmonary Embolism Market Set for Growth with Increasing DVT and PE Cases [Yahoo! Finance]
Low
Report
Global Pulmonary Embolism Market Set for Growth with Increasing DVT and PE Cases [Yahoo! Finance]
12/19
05:04 am
sny
Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades [Yahoo! Finance]
Low
Report
Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades [Yahoo! Finance]